Evaluation of the protection of primates transfused with variant Creutzfeldt-Jakob disease-infected blood products filtered with prion removal devices: a 5-year update.
about
Leucoreduction of blood components: an effective way to increase blood safety?Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?Transmission of scrapie prions to primate after an extended silent incubation period.Prion disease: experimental models and reality.Experimental transfusion of variant CJD-infected blood reveals previously uncharacterised prion disorder in mice and macaque.
P2860
Evaluation of the protection of primates transfused with variant Creutzfeldt-Jakob disease-infected blood products filtered with prion removal devices: a 5-year update.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Evaluation of the protection o ...... oval devices: a 5-year update.
@en
type
label
Evaluation of the protection o ...... oval devices: a 5-year update.
@en
prefLabel
Evaluation of the protection o ...... oval devices: a 5-year update.
@en
P2093
P2860
P356
P1433
P1476
Evaluation of the protection o ...... oval devices: a 5-year update.
@en
P2093
Audrey Culeux
Chryslain Sumian
Emmanuel E Comoy
Evelyne Correia
Jacqueline Mikol
Jean-Philippe Deslys
Nathalie Lescoutra-Etchegaray
Nina Jaffré
Sophie Luccantoni-Freire
Valérie Durand
P2860
P304
P356
10.1111/TRF.12999
P577
2015-02-03T00:00:00Z